Concepedia

Novel Factor Xa Inhibitor for the Treatment of Cerebral Venous and Sinus Thrombosis

C. Geisbüsch, Daniel Richter, Christian Herweh, Peter A. Ringleb, Simon Nagel

Stroke · 2014 · 103 citations · 5 references

DOIFull text

Open access

Abstract

Factor Xa inhibitor showed a similar clinical benefit as VKA in the treatment of cerebral venous thrombosis. Further systematic prospective evaluation is warranted.

References

5

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.3K citations · Full text

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

New England Journal of Medicine · 2010 · 3.2K citations · Full text

Prognosis of Cerebral Vein and Dural Sinus Thrombosis

José M. Ferro, Patrícia Canhão, J. Stam et al. · Stroke · 2004 · 2.3K citations

Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial

U. K. Misra, Jayantee Kalita, Satish Chandra et al. · European Journal of Neurology · 2012 · 156 citations

Influence of Recanalization on Outcome in Dural Sinus Thrombosis

Erwin Stolz, S Trittmacher, Anousha Rahimi et al. · Stroke · 2004 · 119 citations